Spontaneous remission in a patient with therapy-related myelodysplastic syndrome (t-MDS) with monosomy 7

被引:32
|
作者
Renneboog, B
Hansen, V
Heimann, P
DeMulder, A
Janssen, F
Ferster, A
机构
[1] HOP UNIV ENFANTS REINE FABIOLA,HAEMATOONCOL UNIV,B-1020 BRUSSELS,BELGIUM
[2] HOP UNIV ENFANTS REINE FABIOLA,NEPHROL UNIT,B-1020 BRUSSELS,BELGIUM
[3] HOP BRUGMANN,LAB HAEMATOL & CYTOGENET,BRUSSELS,BELGIUM
关键词
t-MDS; myelodysplasia; monosomy; 7; azathioprine;
D O I
10.1046/j.1365-2141.1996.00400.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe a case of spontaneously reversible refractory anaemia, a subtype of myelodysplastic syndrome (MDS), with monosomy 7 secondary to chronic treatment with azathioprine (AZA) in a young renal transplant recipient, AZA was stopped after that conventional cytogenetics and fluorescence in situ hybridization (FISH) had demonstrated the existence of a monosomy 7 clone. 4 months later, haematological values had considerably improved and the karyotypic examination as well as the FISH analysis were normal. The spontaneous remission of this MDS with monosomy 7, which is usually associated with a particularly poor prognosis, could be due to the recovery of a better immunosurveillance following the withdrawal of AZA.
引用
收藏
页码:696 / 698
页数:3
相关论文
共 50 条
  • [21] Chromosomal Abnormalities and TET2 Involvement in Therapy-Related Myelodysplastic Syndromes (t-MDS) and Acute Myeloid Leukemias (t-AML)
    Bernasconi, Paolo
    Dambruoso, Irene
    Boni, Marina
    Astori, Cesare
    Cavigliano, Paola Maria
    Zappasodi, Patrizia
    Giardini, Ilaria
    Rocca, Barbara
    Zappatore, Rita
    Calvello, Celeste
    Caresana, Marilena
    Brusamolino, Ercole
    Castagnola, Carlo
    Lazzarino, Mario
    BLOOD, 2009, 114 (22) : 1020 - 1020
  • [22] FISH TO INVESTIGATE TET2 INVOLVEMENT IN THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (T-MDS) AND ACUTE MYELOID LEUKEMIA (T-AML)
    Bernasconi, P.
    Dambruoso, I.
    Boni, M.
    Astori, C.
    Zappasodi, P.
    Cavigliano, P. M.
    Giardini, I.
    Rocca, B.
    Zappatore, R.
    Calvello, C.
    Caresana, M.
    Brusamolino, E.
    Castagnola, C.
    Lazzarino, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 24 - 24
  • [23] Plasma Cell Neoplasms (PCNs) With Low-Risk, Favorable Gene Expression Subtypes Are More Often Associated With Therapy-Related Myelodysplastic Syndrome (t-MDS)
    Rjoop, Anwar
    Lobo, Rodolfo Henrich
    Pandey, Sounlya
    Alapat, Daisy
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 : S112 - S113
  • [24] Therapy-related myelodysplastic syndrome
    Candelaria, Myrna
    Duenas-Gonzalez, Alfonso
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (05) : 655 - 665
  • [25] A Phase II Study of Clinical Efficacy of Venetoclax in Combination with Azacitidine in Patients with Therapy Related Myelodysplastic Syndrome (t-MDS)
    Borate, Uma M.
    Dvorak-Kornaus, Kaitlyn M.
    Zhao, Qiuhong
    Koenig, Kristin L.
    Eisfeld, Ann-Kathrin
    Madanat, Yazan F.
    BLOOD, 2023, 142
  • [26] Relationship of prior therapy and balanced chromosomal abnormalities in therapy-related myelodysplastic syndrome or acute leukemia (t-MDS/t-AL) of children and adults: Report from an International Workshop.
    Olney, HJ
    Raimondi, SC
    Huo, DZ
    Karrison, TG
    Bloomfield, C
    Rowley, JD
    BLOOD, 2001, 98 (11) : 458A - 458A
  • [27] Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS
    Kuendgen, A.
    Nomdedeu, M.
    Tuechler, H.
    Garcia-Manero, G.
    Komrokji, R. S.
    Sekeres, M. A.
    Della Porta, M. G.
    Cazzola, M.
    DeZern, A. E.
    Roboz, G. J.
    Steensma, D. P.
    Van de Loosdrecht, A. A.
    Schlenk, R. F.
    Grau, J.
    Calvo, X.
    Blum, S.
    Pereira, A.
    Valent, P.
    Costa, D.
    Giagounidis, A.
    Xicoy, B.
    Doehner, H.
    Platzbecker, U.
    Pedro, C.
    Luebbert, M.
    Oiartzabal, I
    Diez-Campelo, M.
    Cedena, M. T.
    Machherndl-Spandl, S.
    Lopez-Pavia, M.
    Baldus, C. D.
    Martinez-de-Sola, M.
    Stauder, R.
    Merchan, B.
    List, A.
    Ganster, C.
    Schroeder, T.
    Voso, M. T.
    Pfeilstoecker, M.
    Sill, H.
    Hildebrandt, B.
    Esteve, J.
    Nomdedeu, B.
    Cobo, F.
    Haas, R.
    Sole, F.
    Germing, U.
    Greenberg, P. L.
    Haase, D.
    Sanz, G.
    LEUKEMIA, 2021, 35 (03) : 835 - 849
  • [28] Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS
    A. Kuendgen
    M. Nomdedeu
    H. Tuechler
    G. Garcia-Manero
    R. S. Komrokji
    M. A. Sekeres
    M. G. Della Porta
    M. Cazzola
    A. E. DeZern
    G. J. Roboz
    D. P. Steensma
    A. A. Van de Loosdrecht
    R. F. Schlenk
    J. Grau
    X. Calvo
    S. Blum
    A. Pereira
    P. Valent
    D. Costa
    A. Giagounidis
    B. Xicoy
    H. Döhner
    U. Platzbecker
    C. Pedro
    M. Lübbert
    I. Oiartzabal
    M. Díez-Campelo
    M. T. Cedena
    S. Machherndl-Spandl
    M. López-Pavía
    C. D. Baldus
    M. Martinez-de-Sola
    R. Stauder
    B. Merchan
    A. List
    C. Ganster
    T. Schroeder
    M. T. Voso
    M. Pfeilstöcker
    H. Sill
    B. Hildebrandt
    J. Esteve
    B. Nomdedeu
    F. Cobo
    R. Haas
    F. Sole
    U. Germing
    P. L. Greenberg
    D. Haase
    G. Sanz
    Leukemia, 2021, 35 : 835 - 849
  • [29] Azacytidine and Vorinostat in Patients with Chronic Lymphocytic Leukemia (CLL) Diagnosed with Therapy-Related Myelodysplastic Syndromes/Acute Myeloid Leukemia (t-MDS/AML)
    Alvarado, Yesid
    Keating, Michael J.
    O'Brien, Susan
    Kantarjian, Hagop M.
    Wierda, William G.
    Sneed, Troy
    Jain, Nitin
    Garcia-Manero, Guillermo
    BLOOD, 2014, 124 (21)
  • [30] THERAPY-RELATED LEUKEMIA AND MYELODYSPLASTIC SYNDROME
    KANTARJIAN, HM
    KEATING, MJ
    SEMINARS IN ONCOLOGY, 1987, 14 (04) : 435 - 443